Powered by

Powered by Portfolio Grader

Loncar Cancer Immunotherapy ETF (CNCR)

20.84 0.09 (0.45%) 11:18 EST
CNCR Stock Quote Delayed 15 Minutes
  • CNCR Stock Chart

  • Historical CNCR Prices

 
Dividend & Yield:       0.35 (1.68%)
P/E:       -
Market Cap:       50.01M
EPS:       -
Volume:       922
Day's Range:       20.72 - 20.93
52wk Range:       16.87 - 32.32
Quotes delayed at least 20 mins.
Historical Data for CNCR
Date Open High Low Volume Close Change %
01/16/19 20.97 21.20 20.85 11,502 20.93 -0.01   -0.05%
01/15/19 20.54 20.95 20.54 4,256 20.94 0.38   1.85%
01/14/19 20.78 20.80 20.50 5,428 20.56 -0.48   -2.28%
01/11/19 21.02 21.15 20.98 2,400 21.04 0.02   0.10%
01/10/19 20.70 21.02 20.47 17,504 21.02 0.30   1.45%
01/09/19 20.80 20.89 20.73 11,550 20.73 0.02   0.10%
01/08/19 20.81 20.81 20.11 15,914 20.71 0.51   2.52%
01/07/19 19.70 20.32 19.70 159,869 20.20 0.73   3.75%
01/04/19 18.94 19.51 18.91 4,100 19.47 1.00   5.41%
01/03/19 18.90 18.90 18.40 3,850 18.47 -0.51   -2.69%
01/02/19 18.66 19.03 18.63 2,578 18.98 0.11   0.58%
12/31/18 18.51 18.88 18.50 63,600 18.87 0.50   2.72%
12/28/18 18.18 18.74 18.16 33,400 18.37 0.21   1.16%
12/27/18 17.83 18.16 17.53 52,921 18.16 0.12   0.67%
12/26/18 17.40 18.05 17.24 29,233 18.04 0.67   3.86%
12/24/18 17.05 17.37 16.87 15,300 17.37 0.16   0.93%
12/21/18 17.94 18.00 17.16 19,100 17.21 -0.66   -3.69%
12/20/18 18.35 18.50 17.75 44,927 17.87 -0.60   -3.25%
12/19/18 19.05 19.36 18.21 33,878 18.47 -0.61   -3.20%
12/18/18 19.95 19.95 18.85 22,936 19.08 -0.42   -2.15%
12/17/18 20.03 20.27 19.44 14,217 19.50 -0.73   -3.61%
12/14/18 20.45 20.55 20.23 9,200 20.23 -0.45   -2.18%
12/13/18 21.10 21.10 20.61 11,592 20.68 -0.32   -1.52%
12/12/18 21.00 21.33 21.00 8,441 21.00 0.21   1.01%
12/11/18 20.88 20.99 20.53 14,428 20.79 -0.01   -0.05%
12/10/18 20.69 20.80 20.21 27,527 20.80 0.14   0.68%
12/07/18 20.94 20.94 20.63 6,500 20.66 -0.28   -1.34%
12/06/18 20.53 21.01 20.53 9,121 20.94 -0.19   -0.90%
12/04/18 21.99 22.30 21.13 23,500 21.13 -0.80   -3.65%
12/03/18 21.59 21.93 21.59 12,209 21.93 0.47   2.19%
11/30/18 21.22 21.52 21.22 8,900 21.46 0.32   1.51%
11/29/18 21.13 21.44 21.13 9,648 21.14 0.04   0.19%
11/28/18 20.67 21.10 20.56 8,721 21.10 0.54   2.63%
11/27/18 20.78 20.78 20.55 5,500 20.56 -0.24   -1.15%
11/26/18 20.63 20.99 20.58 12,990 20.80 0.13   0.63%
11/23/18 20.50 20.76 20.50 2,600 20.67 0.30   1.47%
11/21/18 0.00 20.37 20.37 0 20.37 0.24   1.19%
11/20/18 20.01 20.50 19.88 117,886 20.13 -0.27   -1.32%
11/19/18 20.74 20.81 20.24 13,245 20.40 -0.57   -2.72%
11/16/18 20.48 21.01 20.45 11,300 20.97 0.27   1.30%
11/15/18 20.08 20.70 20.08 4,977 20.70 0.32   1.57%
11/14/18 20.51 20.53 20.16 8,729 20.38 -0.21   -1.02%
11/13/18 20.51 20.81 20.51 9,803 20.59 0.01   0.05%
11/12/18 20.79 20.89 20.40 9,573 20.58 -0.44   -2.09%
11/09/18 21.50 21.50 20.90 8,300 21.02 -0.60   -2.78%
11/08/18 21.69 21.80 21.62 11,939 21.62 0.09   0.42%
11/07/18 21.06 21.71 21.06 24,910 21.53 0.64   3.06%
11/06/18 20.92 21.17 20.88 9,753 20.89 -0.20   -0.95%
11/05/18 21.11 21.18 20.81 8,099 21.08 0.01   0.05%
Loncar Cancer Immunotherapy ETF (CNCR) Stock Rating from Louis Navellier

Navellier Ratings

Powered by Portfolio Grader

Loncar Cancer Immunotherapy ETF Stock Analysis

Rating:

Total Grade:

Analysis Breakdown

CNCR Stock Grade:
Fundamental Grade:
Quantitative Grade:
CNCR Earnings
Earnings Growth:
Earnings Momentum:
Earnings Surprises:
Analyst Earnings Revisions:
CNCR Financial Information
Sales Growth:
Operating Margin Growth:
Cash Flow:
Return on Equity:

Loncar Cancer Immunotherapy ETF Stock: Weekly View

This Week:
Last Week:
Two Weeks Ago:
Get Full Report